NCT02334852View on ClinicalTrials.gov

Registry of Atrial Fibrillation and Embolic Risk in Mexico

CompletedOBSERVATIONAL
Enrollment

1,200

Participants

Timeline

Start Date

December 31, 2014

Primary Completion Date

December 31, 2016

Study Completion Date

March 31, 2017

Conditions
Atrial Fibrillation
Sponsors
All Listed Sponsors
collaborator

Bayer

INDUSTRY

collaborator

Boehringer Ingelheim

INDUSTRY

collaborator

Bristol-Myers Squibb

INDUSTRY

collaborator

Pfizer

INDUSTRY

collaborator

Medicaweb, S.A.C.V.

INDUSTRY

lead

Registro de Fibrilación Auricular y Riesgo Embólico en México

OTHER